M. Ono

Increase in acetyl CoA synthetase activity after phenobarbital treatment.

N. Akamatsu, H. Nakajima, M. Ono, 1975, Biochemical pharmacology.

Motility inhibition and apoptosis are induced by metastasis-suppressing gene product CD82 and its analogue CD9, with concurrent glycosylation.

K. Handa, D. Withers, S. Hakomori, 1999, Cancer research.

Tetraspanin CD9 Is a “Proteolipid,” and Its Interaction with α3 Integrin in Microdomain Is Promoted by GM3 Ganglioside, Leading to Inhibition of Laminin-5-dependent Cell Motility*

K. Handa, D. Withers, S. Hakomori, 2002, The Journal of Biological Chemistry.

Glycosylation affects translocation of integrin, Src, and caveolin into or out of GEM.

K. Handa, S. Hakomori, M. Ono, 2000, Biochemical and biophysical research communications.

Glycosylation effect on membrane domain (GEM) involved in cell adhesion and motility: a preliminary note on functional alpha3, alpha5-CD82 glycosylation complex in ldlD 14 cells.

K. Handa, D. Withers, S. Hakomori, 2000, Biochemical and biophysical research communications.

Glycosylation defining cancer cell motility and invasiveness

S. Hakomori, Masaya Ono, Senitiroh Hakomori, 2003, Glycoconjugate Journal.

Effect of cytochalasin B on lymphocyte stimulation induced by concanavalin A or periodate.

M. Ono, M. Hozumi, 1973, Biochemical and biophysical research communications.

GM3 ganglioside inhibits CD9-facilitated haptotactic cell motility: coexpression of GM3 and CD9 is essential in the downregulation of tumor cell motility and malignancy.

K. Handa, D. Withers, S. Hakomori, 2001, Biochemistry.